Trials / Completed
CompletedNCT01654601
A Study to Compare the Pharmacokinetics Profile of DWCZP Tablet 100mg and Clozaril® Tablet 100mg
Clinical Trials to Compare the Pharmacokinetics Profile of DWCZP Tablet 100mg and Clozaril® Tablet 100mg After a Multi-dose Oral Administration in Schizophrenia Patients
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 28 (actual)
- Sponsor
- Dong Wha Pharmaceutical Co. Ltd. · Industry
- Sex
- All
- Age
- 20 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the pharmacokinetics of oral multiple-dose of DWCZP tablet 100mg.
Detailed description
A randomized, 2-way crossover, open, phase I study to compare the pharmacokinetics profile of DWCZP tablet 100mg and Clozaril® tablet 100mg after a multiple-dose oral administration in schizophrenia patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DWCZP | Multiple dose |
| DRUG | Clozaril | multiple-dose |
Timeline
- Start date
- 2012-06-01
- Primary completion
- 2013-04-01
- Completion
- 2013-08-01
- First posted
- 2012-08-01
- Last updated
- 2017-03-27
- Results posted
- 2014-03-14
Locations
5 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01654601. Inclusion in this directory is not an endorsement.